Suofeng Sun

698 total citations
25 papers, 540 citations indexed

About

Suofeng Sun is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Suofeng Sun has authored 25 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Epidemiology and 10 papers in Cancer Research. Recurrent topics in Suofeng Sun's work include Hepatitis B Virus Studies (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Suofeng Sun is often cited by papers focused on Hepatitis B Virus Studies (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Suofeng Sun collaborates with scholars based in China, Japan and Hong Kong. Suofeng Sun's co-authors include Xiuling Li, Shuangyin Han, Bingyong Zhang, Xiaoying Luo, Bowei Liu, Yuan Li, Zhen Li, Jian Li, Xiuling Li and Zhiyu Yang and has published in prestigious journals such as Scientific Reports, Frontiers in Microbiology and BioMed Research International.

In The Last Decade

Suofeng Sun

24 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suofeng Sun China 14 315 249 144 90 79 25 540
Haolin Yun China 12 430 1.4× 233 0.9× 192 1.3× 69 0.8× 70 0.9× 13 617
Hua Sun China 7 213 0.7× 213 0.9× 93 0.6× 84 0.9× 46 0.6× 10 401
Ersin Akgöllü Türkiye 14 373 1.2× 274 1.1× 115 0.8× 57 0.6× 31 0.4× 24 575
Federico Pio Fabrizio Italy 12 212 0.7× 77 0.3× 124 0.9× 94 1.0× 73 0.9× 33 470
Fan Zhou China 10 299 0.9× 96 0.4× 94 0.7× 63 0.7× 32 0.4× 20 506
Aynur Bekar Türkiye 14 383 1.2× 277 1.1× 107 0.7× 48 0.5× 31 0.4× 20 569
Linhua Ji China 13 296 0.9× 150 0.6× 82 0.6× 36 0.4× 53 0.7× 35 500
Xiaoxin Mu China 12 277 0.9× 136 0.5× 93 0.6× 66 0.7× 32 0.4× 18 469
Ceen‐Ming Tang United Kingdom 6 160 0.5× 151 0.6× 150 1.0× 88 1.0× 48 0.6× 8 419

Countries citing papers authored by Suofeng Sun

Since Specialization
Citations

This map shows the geographic impact of Suofeng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suofeng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suofeng Sun more than expected).

Fields of papers citing papers by Suofeng Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suofeng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suofeng Sun. The network helps show where Suofeng Sun may publish in the future.

Co-authorship network of co-authors of Suofeng Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Suofeng Sun. A scholar is included among the top collaborators of Suofeng Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suofeng Sun. Suofeng Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Hui, Shuang Hu, Ziyang Liu, et al.. (2023). HBx Regulation on HBV Pregenome Promoter in the Episomal Form Versus the Integrated Form. Discovery Medicine. 35(175). 124–124. 1 indexed citations
2.
Li, Yuan, et al.. (2023). Protein Acetylation Increased Risk of Fibrosis-Related Liver Cancer. Journal of Oncology. 2023. 1–12. 2 indexed citations
3.
Zhu, Kangning, Suofeng Sun, Fengxia Guo, & Lan Gao. (2022). Impaired Fanconi anemia pathway causes DNA hypomethylation in human angiosarcomas. Human Cell. 35(5). 1602–1611. 1 indexed citations
5.
Lü, Di, Zhiyu Yang, Shanjun Gao, et al.. (2021). ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation. Annals of Translational Medicine. 9(8). 661–661. 38 indexed citations
6.
Luo, Xiaoying, Yangqiu Bai, Shuli He, et al.. (2021). Sirtuin 1 ameliorates defenestration in hepatic sinusoidal endothelial cells during liver fibrosis via inhibiting stress‐induced premature senescence. Cell Proliferation. 54(3). e12991–e12991. 32 indexed citations
7.
Liu, Bowei, Wei Wang, Suofeng Sun, et al.. (2020). <p>Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231</p>. OncoTargets and Therapy. Volume 13. 11347–11358. 14 indexed citations
8.
Sun, Suofeng, Huijuan Zhang, Yu Wang, et al.. (2020). Proteomic Analysis of Human Esophageal Cancer Using Tandem Mass Tag Quantifications. BioMed Research International. 2020(1). 5849323–5849323. 6 indexed citations
9.
Sun, Suofeng, Jing Gao, Yuan Li, et al.. (2020). A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signaling. Journal of Experimental & Clinical Cancer Research. 39(1). 252–252. 49 indexed citations
10.
Wang, Wei, Bowei Liu, Suofeng Sun, et al.. (2020). <p>Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 1649–1659. 12 indexed citations
11.
Yang, Zhiyu, Shanjun Gao, Suofeng Sun, et al.. (2020). ACADSB regulates ferroptosis and affects the migration, invasion, and proliferation of colorectal cancer cells. Cell Biology International. 44(11). 2334–2343. 50 indexed citations
12.
Shu, Weigang, Zhi Pang, Jian Lin, et al.. (2019). Anti-TNF-α Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease. Mediators of Inflammation. 2019. 1–13. 19 indexed citations
13.
Sun, Suofeng, Yuan Li, Shuangyin Han, et al.. (2019). A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma. BMC Medical Genomics. 12(1). 147–147. 23 indexed citations
14.
Luo, Xiaoying, Jun Li, Yangqiu Bai, et al.. (2019). Insulin-like growth factor-1 attenuates oxidative stress-induced hepatocyte premature senescence in liver fibrogenesis via regulating nuclear p53–progerin interaction. Cell Death and Disease. 10(6). 451–451. 41 indexed citations
15.
Nakashima, Kenji, et al.. (2019). Cell Type Diversity in Hepatitis B Virus RNA Splicing and Its Regulation. Frontiers in Microbiology. 10. 207–207. 18 indexed citations
16.
Sun, Suofeng, Wei Wang, Xiaoying Luo, et al.. (2019). Circular RNA circ-ADD3 inhibits hepatocellular carcinoma metastasis through facilitating EZH2 degradation via CDK1-mediated ubiquitination.. PubMed. 9(8). 1695–1707. 59 indexed citations
17.
Ma, Caiyun, Wei Wu, Ritian Lin, et al.. (2018). Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD. Journal of Crohn s and Colitis. 13(4). 510–524. 35 indexed citations
18.
Sun, Suofeng, Kenji Nakashima, Masahiko Ito, et al.. (2017). Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression. Scientific Reports. 7(1). 12874–12874. 23 indexed citations
19.
Ito, Masahiko, Suofeng Sun, Takasuke Fukuhara, et al.. (2017). Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation. Oncotarget. 8(33). 53899–53915. 6 indexed citations
20.
Li, Yuan, et al.. (2016). LUC7L3/CROP inhibits replication of hepatitis B virus via suppressing enhancer II/basal core promoter activity. Scientific Reports. 6(1). 36741–36741. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026